Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19

Background 

This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts on  Immunization (SAGE) at its extraordinary meeting on 21 January 2021 [1].

Read more…